Table 1 Pathways identified by KEGG pathway analysis on the 3rd day after ventral combined with dorsal root avulsion
Pathway | Count | p-value |
|---|---|---|
Calcium signaling pathway | 33 | 3.11E-04 |
MAPK signaling pathway | 43 | 4.35E-04 |
Amyotrophic lateral sclerosis (ALS) | 15 | 8.53E-04 |
Adipocytokine signaling pathway | 16 | 0.001076 |
Apoptosis | 18 | 0.001945 |
PPAR signaling pathway | 16 | 0.002004 |
Long-term depression | 15 | 0.003117 |
Renal cell carcinoma | 15 | 0.004136 |
Long-term potentiation | 14 | 0.008307 |
Tight junction | 22 | 0.008915 |
Fc gamma R-mediated phagocytosis | 16 | 0.01576 |
Chemokine signaling pathway | 26 | 0.015924 |
Neuroactive ligand-receptor interaction | 36 | 0.018913 |
Cytokine-cytokine receptor interaction | 28 | 0.027292 |
Glycerophospholipid metabolism | 12 | 0.02741 |
Oocyte meiosis | 18 | 0.0284 |
Ether lipid metabolism | 8 | 0.035229 |
Gap junction | 14 | 0.036906 |
p53 signaling pathway | 12 | 0.041325 |
Natural killer cell mediated cytotoxicity | 16 | 0.044603 |
Alzheimer's disease | 27 | 0.044866 |
T cell receptor signaling pathway | 17 | 0.046169 |
ABC transporters | 9 | 0.049088 |